Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More.

Vitale M, Cantoni C, Della Chiesa M, Ferlazzo G, Carlomagno S, Pende D, Falco M, Pessino A, Muccio L, De Maria A, Marcenaro E, Moretta L, Sivori S.

Front Immunol. 2019 Jun 19;10:1415. doi: 10.3389/fimmu.2019.01415. eCollection 2019. Review.

2.

PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells.

Pesce S, Greppi M, Grossi F, Del Zotto G, Moretta L, Sivori S, Genova C, Marcenaro E.

Front Immunol. 2019 Jun 4;10:1242. doi: 10.3389/fimmu.2019.01242. eCollection 2019. Review.

3.
4.

NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans.

Parodi M, Favoreel H, Candiano G, Gaggero S, Sivori S, Mingari MC, Moretta L, Vitale M, Cantoni C.

Front Immunol. 2019 Apr 9;10:719. doi: 10.3389/fimmu.2019.00719. eCollection 2019. Review.

5.

Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer.

Greppi M, Tabellini G, Patrizi O, Candiani S, Decensi A, Parolini S, Sivori S, Pesce S, Paleari L, Marcenaro E.

Int J Mol Sci. 2019 Feb 19;20(4). pii: E890. doi: 10.3390/ijms20040890. Review.

6.

Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.

Sivori S, Vacca P, Del Zotto G, Munari E, Mingari MC, Moretta L.

Cell Mol Immunol. 2019 May;16(5):430-441. doi: 10.1038/s41423-019-0206-4. Epub 2019 Feb 18. Review.

PMID:
30778167
7.

New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.

Pesce S, Squillario M, Greppi M, Loiacono F, Moretta L, Moretta A, Sivori S, Castagnola P, Barla A, Candiani S, Marcenaro E.

Front Immunol. 2018 Oct 15;9:2360. doi: 10.3389/fimmu.2018.02360. eCollection 2018.

8.

Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content.

Bono M, Pende D, Bertaina A, Moretta A, Della Chiesa M, Sivori S, Zecca M, Locatelli F, Moretta L, Bottino C, Falco M.

J Immunol. 2018 Sep 1;201(5):1460-1467. doi: 10.4049/jimmunol.1800564. Epub 2018 Aug 1.

PMID:
30068594
9.

Late Development of FcεRγneg Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients.

Muccio L, Falco M, Bertaina A, Locatelli F, Frassoni F, Sivori S, Moretta L, Moretta A, Della Chiesa M.

Front Immunol. 2018 May 15;9:1050. doi: 10.3389/fimmu.2018.01050. eCollection 2018.

10.

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells.

Ziegler S, Weiss E, Schmitt AL, Schlegel J, Burgert A, Terpitz U, Sauer M, Moretta L, Sivori S, Leonhardt I, Kurzai O, Einsele H, Loeffler J.

Sci Rep. 2017 Jul 21;7(1):6138. doi: 10.1038/s41598-017-06238-4.

11.

KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing.

Carlomagno S, Falco M, Bono M, Alicata C, Garbarino L, Mazzocco M, Moretta L, Moretta A, Sivori S.

Front Immunol. 2017 May 26;8:581. doi: 10.3389/fimmu.2017.00581. eCollection 2017.

12.

Markers and function of human NK cells in normal and pathological conditions.

Del Zotto G, Marcenaro E, Vacca P, Sivori S, Pende D, Della Chiesa M, Moretta F, Ingegnere T, Mingari MC, Moretta A, Moretta L.

Cytometry B Clin Cytom. 2017 Mar;92(2):100-114. doi: 10.1002/cyto.b.21508. Epub 2017 Feb 12. Review.

13.

Features of Memory-Like and PD-1(+) Human NK Cell Subsets.

Della Chiesa M, Pesce S, Muccio L, Carlomagno S, Sivori S, Moretta A, Marcenaro E.

Front Immunol. 2016 Sep 14;7:351. doi: 10.3389/fimmu.2016.00351. eCollection 2016. Review.

14.

Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.

Laroni A, Armentani E, Kerlero de Rosbo N, Ivaldi F, Marcenaro E, Sivori S, Gandhi R, Weiner HL, Moretta A, Mancardi GL, Uccelli A.

J Autoimmun. 2016 Aug;72:8-18. doi: 10.1016/j.jaut.2016.04.003. Epub 2016 May 4.

15.

Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?

Della Chiesa M, Sivori S, Carlomagno S, Moretta L, Moretta A.

Front Immunol. 2015 Nov 9;6:573. doi: 10.3389/fimmu.2015.00573. eCollection 2015. Review.

16.

Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment.

Parodi M, Pedrazzi M, Cantoni C, Averna M, Patrone M, Cavaletto M, Spertino S, Pende D, Balsamo M, Pietra G, Sivori S, Carlomagno S, Mingari MC, Moretta L, Sparatore B, Vitale M.

Oncoimmunology. 2015 May 29;4(12):e1052353. eCollection 2015 Dec.

17.

Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles.

Pesce S, Carlomagno S, Moretta A, Sivori S, Marcenaro E.

J Immunol Res. 2015;2015:754373. doi: 10.1155/2015/754373. Epub 2015 Apr 16.

18.

NK receptors: tools for a polyvalent cell family.

Sivori S, Olive D, López-Botet M, Vitale M.

Front Immunol. 2014 Dec 3;5:617. doi: 10.3389/fimmu.2014.00617. eCollection 2014. No abstract available.

19.

TLR/NCR/KIR: Which One to Use and When?

Sivori S, Carlomagno S, Pesce S, Moretta A, Vitale M, Marcenaro E.

Front Immunol. 2014 Mar 19;5:105. doi: 10.3389/fimmu.2014.00105. eCollection 2014. Review.

20.

Human NK cell response to pathogens.

Della Chiesa M, Marcenaro E, Sivori S, Carlomagno S, Pesce S, Moretta A.

Semin Immunol. 2014 Apr;26(2):152-60. doi: 10.1016/j.smim.2014.02.001. Epub 2014 Feb 28. Review.

PMID:
24582551
21.

KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts.

Marcenaro E, Pesce S, Sivori S, Carlomagno S, Moretta L, Moretta A.

Blood. 2013 Apr 25;121(17):3396-401. doi: 10.1182/blood-2012-09-458752. Epub 2013 Feb 28.

22.

NK/DC crosstalk in anti-viral response.

Marcenaro E, Carlomagno S, Pesce S, Moretta A, Sivori S.

Adv Exp Med Biol. 2012;946:295-308. doi: 10.1007/978-1-4614-0106-3_17. Review.

PMID:
21948375
23.

NK cells and their receptors during viral infections.

Marcenaro E, Carlomagno S, Pesce S, Della Chiesa M, Parolini S, Moretta A, Sivori S.

Immunotherapy. 2011 Sep;3(9):1075-86. doi: 10.2217/imt.11.99. Review.

PMID:
21913830
24.

Bridging innate NK cell functions with adaptive immunity.

Marcenaro E, Carlomagno S, Pesce S, Moretta A, Sivori S.

Adv Exp Med Biol. 2011;780:45-55. doi: 10.1007/978-1-4419-5632-3_5. Review.

PMID:
21842364
25.

Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation.

Marcenaro E, Carlomagno S, Pesce S, Della Chiesa M, Moretta A, Sivori S.

J Leukoc Biol. 2011 Oct;90(4):661-7. doi: 10.1189/jlb.0311137. Epub 2011 Jul 26. Review.

PMID:
21791599
26.

Human NK receptors: from the molecules to the therapy of high risk leukemias.

Moretta L, Locatelli F, Pende D, Sivori S, Falco M, Bottino C, Mingari MC, Moretta A.

FEBS Lett. 2011 Jun 6;585(11):1563-7. doi: 10.1016/j.febslet.2011.04.061. Epub 2011 May 7. Review.

27.

Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.

Sivori S, Carlomagno S, Falco M, Romeo E, Moretta L, Moretta A.

Blood. 2011 Apr 21;117(16):4284-92. doi: 10.1182/blood-2010-10-316125. Epub 2011 Feb 25.

28.

Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients.

Bensussan A, Remtoula N, Sivori S, Bagot M, Moretta A, Marie-Cardine A.

J Invest Dermatol. 2011 Apr;131(4):969-76. doi: 10.1038/jid.2010.404. Epub 2010 Dec 30.

29.

Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products.

Sivori S, Falco M, Moretta L, Moretta A.

Trends Immunol. 2010 Aug;31(8):289-94. doi: 10.1016/j.it.2010.05.007. Epub 2010 Jul 12.

PMID:
20630802
30.

A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.

Sivori S, Falco M, Carlomagno S, Romeo E, Soldani C, Bensussan A, Viola A, Moretta L, Moretta A.

Blood. 2010 Sep 9;116(10):1637-47. doi: 10.1182/blood-2009-12-256586. Epub 2010 Feb 10.

31.

IFN-alpha-mediated increase in cytolytic activity of maturing NK cell upon exposure to HSV-infected myelomonocytes.

Costa P, Sivori S, Bozzano F, Martini I, Moretta A, Moretta L, De Maria A.

Eur J Immunol. 2009 Jan;39(1):147-58. doi: 10.1002/eji.200838532. Erratum in: Eur J Immunol. 2009 Mar;39(3):912.

32.

Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors.

Sivori S, Falco M, Carlomagno S, Romeo E, Moretta L, Moretta A.

Int Immunol. 2007 Dec;19(12):1341-8. Epub 2007 Oct 25.

PMID:
17962643
33.

In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes.

Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S, Beri R, Dolcino M, Valletta E, Corrocher R, Puccetti A.

PLoS Med. 2006 Sep;3(9):e358.

34.

Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells.

Sivori S, Carlomagno S, Moretta L, Moretta A.

Eur J Immunol. 2006 Apr;36(4):961-7.

35.

Early liaisons between cells of the innate immune system in inflamed peripheral tissues.

Moretta A, Marcenaro E, Sivori S, Della Chiesa M, Vitale M, Moretta L.

Trends Immunol. 2005 Dec;26(12):668-75. Epub 2005 Sep 28. Review.

PMID:
16198147
36.

Pathogen-induced private conversations between natural killer and dendritic cells.

Della Chiesa M, Sivori S, Castriconi R, Marcenaro E, Moretta A.

Trends Microbiol. 2005 Mar;13(3):128-36. Review.

PMID:
15737731
37.

CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells.

Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L, Moretta A.

Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10116-21. Epub 2004 Jun 24.

38.

NK cells: innate immunity against hematological malignancies?

Costello RT, Fauriat C, Sivori S, Marcenaro E, Olive D.

Trends Immunol. 2004 Jun;25(6):328-33. Review.

PMID:
15145323
39.

Natural killer cell-triggering receptors in patients with acute leukaemia.

Fauriat C, Marcenaro E, Sivori S, Rey J, Gastaut JA, Moretta A, Olive D, Costello RT.

Leuk Lymphoma. 2003 Oct;44(10):1683-9. Review.

PMID:
14692519
40.

IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors.

Sivori S, Cantoni C, Parolini S, Marcenaro E, Conte R, Moretta L, Moretta A.

Eur J Immunol. 2003 Dec;33(12):3439-47.

41.

CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.

Marcenaro E, Augugliaro R, Falco M, Castriconi R, Parolini S, Sivori S, Romeo E, Millo R, Moretta L, Bottino C, Moretta A.

Eur J Immunol. 2003 Dec;33(12):3367-76.

42.

Natural killer lymphocytes: "null cells" no more.

Moretta A, Bottino C, Sivori S, Marcenaro E, Castriconi R, Della Chiesa M, Carlomagno S, Augugliaro R, Nanni M, Vitale M, Millo R.

Ital J Anat Embryol. 2001 Oct-Dec;106(4):335-42. Review.

PMID:
12003235
43.

A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.

Costello RT, Sivori S, Mallet F, Sainty D, Arnoulet C, Reviron D, Gastaut JA, Moretta A, Olive D.

Leukemia. 2002 May;16(5):855-60.

44.

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.

Costello RT, Sivori S, Marcenaro E, Lafage-Pochitaloff M, Mozziconacci MJ, Reviron D, Gastaut JA, Pende D, Olive D, Moretta A.

Blood. 2002 May 15;99(10):3661-7.

45.

Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation.

Sivori S, Falco M, Marcenaro E, Parolini S, Biassoni R, Bottino C, Moretta L, Moretta A.

Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4526-31. Epub 2002 Mar 26.

46.

Human natural killer cell receptors and co-receptors.

Biassoni R, Cantoni C, Pende D, Sivori S, Parolini S, Vitale M, Bottino C, Moretta A.

Immunol Rev. 2001 Jun;181:203-14. Review.

PMID:
11513142
47.

NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.

Bottino C, Falco M, Parolini S, Marcenaro E, Augugliaro R, Sivori S, Landi E, Biassoni R, Notarangelo LD, Moretta L, Moretta A.

J Exp Med. 2001 Aug 6;194(3):235-46. Erratum in: J Exp Med 2001 Sep 3;194(5):following 703.

48.

CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor.

Bagot M, Moretta A, Sivori S, Biassoni R, Cantoni C, Bottino C, Boumsell L, Bensussan A.

Blood. 2001 Mar 1;97(5):1388-91.

49.
50.

Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines.

Sivori S, Parolini S, Marcenaro E, Millo R, Bottino C, Moretta A.

Hum Immunol. 2000 Nov;61(11):1055-8.

PMID:
11137207

Supplemental Content

Loading ...
Support Center